MedCity News March 24, 2024
A new report from the Peterson Health Technology Institute analyzed eight digital diabetes management tools. It found that the tools don’t provide meaningful clinical benefits and increase healthcare spending.
Digital diabetes management tools fail to provide meaningful clinical benefits and increase health spending, a new report from the Peterson Health Technology Institute (PHTI) shows.
This is PHTI’s inaugural report after launching in July as an independent evaluator of digital health solutions. The analysis evaluated eight digital tools that support people with type 2 diabetes: DarioHealth, Glooko, Omada, Perry Health, Teladoc’s Livongo, Verily’s Onduo, Vida, and Virta. These solutions use three approaches:
- Remote patient monitoring (Glooko)
- Behavior and lifestyle modification (DarioHealth, Omada, Perry Health, Livongo, Onduo and Vida)
- Nutritional...
Today's Sponsors
Today's Sponsor